CLINICAL ROLE -
Meeting the Challenge of Employee Engagement in the Ever-Changing Specialty Pharmacy
Leaders in specialty pharmacy must work to improve employee engagement in order to boost the customer experience.
Read More
PBM Reports Limiting Commercial Drug Spending Increases to Less Than 1%
Prime Therapeutics reduced Medicare spending on pain drugs by 12% in the first half of 2017.
How Rheumatoid Arthritis Affects Patients in the Workplace
Many patients with rheumatoid arthritis feel their employers do not understand their condition.
Legislators Push for National Diabetes Commission
The National Clinical Care Commission Act would better coordinate diabetes research.
HCV Treatment Success Not Dependent on Type of Provider
Patients with hepatitis C virus achieve treatment success with specialists, primary care physicians, and nurse practitioners.
Hypertension During Pregnancy Increases Child's Obesity Risks
Findings highlight the need to monitor blood pressure during pregnancy, especially in the second trimester.
Trending News Today: Ending ACA Subsidies Could Cost $200 Billion in the Next Decade
Top news of the day from across the healthcare landscape.
Trending News Today: Negative Emotions May Cause Cancer Patients to Adopt Healthier Behaviors
Stelara Approved to Treat Plaque Psoriasis in Adolescents
Ustekinumab (Stelara) treats moderate to severe plaque psoriasis in adolescents who are candidates for phototherapy or systemic therapy.
The Role of Veterinarians in Preventing Prescription Opioid Abuse
Veterinarians can prescribe highly-addictive and powerful painkillers for pets.
FDA Approves Once-Daily Neuropathic Pain Drug
Lyrica extended-release tablets treat neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia.
Is the 3-Year PharmD the Best Program for the Future?
Why did a top college of pharmacy switch to a 3-year program from a 4-year one?
Uninsured Rate in the Suburbs Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Pharmacy Week in Review: October 13, 2017
A look at last week's top stories in the world of pharmacy.
Watch
5 New FDA Approvals to Know from September 2017
Learn about the new products and expanded indications approved by the FDA in September 2017.
Protein Could Reverse Cell Damage from Cancer Treatment
Novel discovery could lead to targeted cancer therapies.
Uptake of Integrated Electronic Health Records Remains Slow
Electronic health record adoption is high, but integrated records pose a challenge.
Gene Expression Modification Shows Promise as Leukemia Treatment
Targeting RNA methylation could treat acute myeloid leukemia.
Tobacco Companies Ordered to Disclose Harms of Cigarettes, Other Products
Judge orders tobacco companies to inform Americans about the harmful and addictive properties of smoking.
Trending News Today: Trump Signs Sweeping Executive Order on Healthcare
Trending News Today: FDA Panel Issues Positive Opinion for Novel Gene Therapy
Optimizing Drug Plasma Levels Predicts SVR in Hepatitis C Patients
The lack of association of SVR with ribavirin dose reflects the wide variance in plasma levels between individuals with hepatitis C receiving the same weight-based dosage.
Hepatitis C Antivirals Safe in Heart Transplant Patients
Heart transplant patients with hepatitis C often cannot not tolerate interferon-based regimens due to cardiac toxicity and other heart-related problems.
Congress Fights DIR Fees Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
FDA Supports Approval of Gene Therapy for Inherited Retinal Disease
Voretigene neparvovec (Luxturna) treats biallelic RPE65-mediated inherited retinal disease.
What Pharmacists Need to Know About President Trump's Health Care Executive Order
Secretary of Labor to consider expanding access to Association Health Plans, which could allow employers to form groups across state lines.
New Drugs Introduced in 2017: Dermatology
This year, the FDA is on pace to approve about 38 new medications. Here is a look at some new dermatology treatments.
FDA OKs Pregabalin Extended-release Once-Daily Tablets for Neuropathic Pain
The tablets did not get approval for managing fibromyalgia, however, according to a press release from Pfizer.
Key Points of President Trump's Health Care Executive Order
The plan calls for sale of insurance across state lines.
